iShares U.S. Pharmaceuticals ETF (IHE)

iShares U.S. Pharmaceuticals ETF trades under the ticker IHE. The share price is $108.55, down 0.99% on the day. Price as of 17 Nov 2026, 17:34 UTC, from Yahoo Finance.

Key facts

Share price
$108.55−0.99% today
P/E ratio
26.9×last 12 months
200-week average
$73.0149% above

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

iShares U.S. Pharmaceuticals ETF in more detail

IHE trades at 26.9× its last twelve months' earnings. It sits 49% above its 200-week average of $73.01.

1 of the superinvestors tracked here hold IHE, including Ken Fisher (0.1% of the portfolio).

Superinvestors holding IHE

1 of the investors tracked here report a position in their latest 13F filing.

iShares U.S. Pharmaceuticals ETF (IHE): questions and answers

What is IHE's P/E ratio?

iShares U.S. Pharmaceuticals ETF trades at 26.9× its last twelve months' earnings.

Is IHE above its 200-week moving average?

Yes. IHE is 48.7% above its 200-week average of $73.01. Long-term investors watch that line because strong companies rarely trade below it for long.

Does IHE pay a dividend?

iShares U.S. Pharmaceuticals ETF does not currently pay a regular dividend.

Which famous investors own IHE?

In their latest quarterly filings, Ken Fisher (0.1% of the portfolio) hold IHE. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “iShares U.S. Pharmaceuticals ETF (IHE) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/IHE

Underlying data: Yahoo Finance; company filings with the SEC.